Skip to search.
 TSX Up 0.29% TSX Ventures Up 0.05%

Seattle Genetics, Inc. (SGEN)

-NasdaqGS
45.36 Up 0.06(0.13%) 4:00PM EDT
|After Hours : 45.36 0.00 (0.00%) 4:36PM EDT
Prev Close:45.30
Open:45.36
Bid:32.95 x 100
Ask:N/A
1y Target Est:49.00
Beta:1.83674
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:44.94 - 45.62
52wk Range:26.02 - 49.66
Volume:437,056
Avg Vol (3m):744,836
Market Cap:6.37B
P/E (ttm):N/A
EPS (ttm):-0.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SGENUp 0.13%6.37B
IMGNDown 0.68%252.52M
PFEUp 0.83%212.96B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.00
Quarterly EPS Est (Sep-16) :-0.30
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-2.53

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes targeted therapies for the treatment of cancer worldwide. It markets ADCETRIS (brentuximab vedotin), an antibody-drug conjugate for the treatment of relapsed Hodgkin lymp... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback